BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28730299)

  • 1. Prophylactic etanercept treatment in cisplatin ototoxicity.
    Dasli S; Topdag M; Mutlu A; Kara A; Ozturk M
    Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3577-3583. PubMed ID: 28730299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal curcumin and vitamin E combination for the treatment of cisplatin-induced ototoxicity in rats.
    Soyalıç H; Gevrek F; Koç S; Avcu M; Metin M; Aladağ İ
    Int J Pediatr Otorhinolaryngol; 2016 Oct; 89():173-8. PubMed ID: 27619052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
    Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
    Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
    Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
    Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin as a protective agent in cisplatin-induced ototoxicity.
    Bekmez Bilmez ZE; Aydin S; Şanli A; Altintoprak N; Demir MG; Atalay Erdoğan B; Kösemihal E
    Cancer Chemother Pharmacol; 2016 Apr; 77(4):875-9. PubMed ID: 26865281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ozone (O
    Koçak HE; Taşkın Ü; Aydın S; Oktay MF; Altınay S; Çelik DS; Yücebaş K; Altaş B
    Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4153-4159. PubMed ID: 27221387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
    Biró K
    Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the protective effect of α-lipoic acid on cisplatin ototoxicity using distortion-product otoacoustic emission measurements: an experimental animal study.
    Ozkul Y; Songu M; Basoglu MS; Ozturkcan S; Katilmis H
    J Craniofac Surg; 2014 Jul; 25(4):1515-8. PubMed ID: 24905944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the protective efficacy between intratympanic dexamethasone and resveratrol treatments against cisplatin-induced ototoxicity: an experimental study.
    Simsek G; Taş BM; Muluk NB; Azman M; Kılıç R
    Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3287-3293. PubMed ID: 31531774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.
    Biro K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
    Oncology; 2006; 70(3):177-84. PubMed ID: 16757924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of eugenol against cisplatin-induced ototoxicity.
    Sakat MS; Kilic K; Akdemir FNE; Yildirim S; Eser G; Kiziltunc A
    Braz J Otorhinolaryngol; 2019; 85(6):766-773. PubMed ID: 30126770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
    Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
    Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion-product otoacoustic emissions and auditory brainstem responses sensitivity assessment in cisplatin-induced ototoxicity in rats.
    Freitas MR; Silva VC; Brito GA; Carvalho Junior JV; Gomes Junior RM; Ribeiro Rde A
    Braz J Otorhinolaryngol; 2009; 75(4):476-84. PubMed ID: 19784413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model.
    Dille MF; McMillan GP; Reavis KM; Jacobs P; Fausti SA; Konrad-Martin D
    J Acoust Soc Am; 2010 Sep; 128(3):1163-74. PubMed ID: 20815453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Protective Effect of Cortexin on Cisplatin-Induced Ototoxicity.
    Eroğlu O; Karlıdağ T; Kuloğlu T; Keleş E; Kaygusuz İ; Yalçın Ş
    J Int Adv Otol; 2018 Apr; 14(1):27-33. PubMed ID: 29092803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible protective effect of sertraline against cisplatin-induced ototoxicity: an experimental study.
    Ozturk M; Ucar S; Sarı F; Erdogan S; Topdag M; Iseri M
    ScientificWorldJournal; 2013; 2013():523480. PubMed ID: 24198723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of gallic acid against cisplatin-induced ototoxicity in rats.
    Kilic K; Sakat MS; Akdemir FNE; Yildirim S; Saglam YS; Askin S
    Braz J Otorhinolaryngol; 2019; 85(3):267-274. PubMed ID: 29673779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity.
    Olgun Y; Kırkım G; Kolatan E; Kıray M; Bagrıyanık A; Olgun A; Kızmazoglu DC; Ellıdokuz H; Serbetcıoglu B; Altun Z; Aktas S; Yılmaz O; Günerı EA
    Laryngoscope; 2014 Mar; 124(3):760-6. PubMed ID: 23900991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective effect of erdosteine against ototoxicity induced by cisplatin in rats.
    Kalcioglu MT; Kizilay A; Gulec M; Karatas E; Iraz M; Akyol O; Egri M; Ozturan O
    Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):856-63. PubMed ID: 15742177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.